跳至主要内容
临床试验/NCT07422961
NCT07422961已完成不适用

Response to Endurance Training in Postmenopausal Women With Exercise Intolerance.

University of Poitiers1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2022年9月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
1
主要终点
Cardiorespiratory fitness

研究概览

简要总结

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide and represent a major public health challenge, with growing evidence highlighting important sex-related differences in their epidemiology, clinical presentation, and pathophysiology. In particular, menopause is associated with an increased cardiovascular risk, likely due to the decline in sex hormones and related changes in cardiac structure and function, vascular properties, and metabolic regulation. Several studies show that physical activity and, more specifically, aerobic training improves exercise tolerance and quality of life in patients. However, no studies have evaluated the effects of hormonal status, despite numerous studies on healthy subjects highlighting the influence of sex hormones on cardiovascular responses to acute and chronic exercise.

详细描述

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide and represent a major public health challenge. Importantly, growing evidence highlights significant sex-related differences in the epidemiology, clinical presentation, and pathophysiology of cardiovascular diseases. In particular, postmenopause represents a period of life associated with an increased risk of CVD.

Several physiological mechanisms may underlie these sex-related disparities. Differences in cardiac structure and function, vascular properties, and metabolic regulation contribute to distinct cardiovascular health between men and women. Moreover, the transition to menopause and the associated decline in circulating sex hormones are thought to play a key role in cardiovascular remodeling and functional alterations.

For many years, physical activity has been considered a first-line non-pharmacological strategy in the prevention and treatment of cardiovascular diseases. More specifically, aerobic training has been shown to improves exercise tolerance and quality of life in patients. Indeed, sentinel studies highlight an improvement in aerobic power (VO2 peak) linked to peripheral adaptations (increase in the arteriovenous difference in O2 in the muscles used) and not to central adaptations (no changes in systolic and diastolic functions). However, these studies did not assess the effects of hormonal status , whereas numerous studies on healthy subjects have highlighted the influence of sex hormones on cardiovascular responses to acute and chronic exercise.

The aims of this study:

  • Evaluate the effects of 24 aerobic training sessions (over 8-12 weeks) on exercise tolerance in postmenopausal women (peak VO2 and exercise dyspnea using the Borg scale).
  • Second, evaluate the effects of 24 aerobic training sessions key indices of cardiovascular physiology (e.g., arterial stiffness, endothelial dysfunction, and muscle oxygenation).
  • Thirds, to evaluate the effects of the training sessions on the quality-of-life score of postmenopausal women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
40 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Postmenopausal women under 70 years of age (absence of menstruation for 12 consecutive months and estradiol < 20 pg/mL and/or FSH > 40 mIU/mL), presenting with unexplained exertional dyspnea.
  • COVID-19 vaccination.
  • Echocardiographic ejection fraction > 50% and NT-proBNP < 220 pg/mL.
  • Women in sinus rhythm or with paroxysmal or permanent atrial fibrillation.
  • Women considered physically inactive according to WHO recommendations (150 minutes of moderate-intensity endurance activity per week, or at least 75 minutes of vigorous-intensity endurance activity, or an equivalent combination of moderate- and vigorous-intensity activity.

排除标准

  • Women with significant coronary heart disease, severe valvular disease (grade III or IV/IV), significant hypertrophic or hypertensive heart disease (LVH with wall thickness ≥ 13 mm), infiltrative disease (amyloidosis, Fabry disease, etc.), constrictive disease, or significant and/or progressive arrhythmic disease (ventricular arrhythmia).
  • Women with significant obesity (BMI > 30 kg/m²).
  • Unstable women (systolic blood pressure < 100 mmHg, resting heart rate > 100 bpm) or women with clinical congestion (cardiac-related lower limb edema, pulmonary crackles).
  • Women with pulmonary function tests indicating significant respiratory disease (FEV₁/FVC < 0.7, TLC < LLN).
  • Women with chronic renal failure with creatinine clearance < 30 mL/min (MDRD) or on dialysis.
  • Women with anemia (Hb < 12 g/dL).
  • Women with uncontrolled hypo- or hyperthyroidism (abnormal TSH).
  • Women who have undergone left breast augmentation (implant).
  • Women under legal guardianship or conservatorship.

研究组 & 干预措施

Training

Experimental

24 sessions of adapted physical activity at moderate intensity (aerobic exercise)

干预措施: Training (Other)

Control

No Intervention

Maintaining lifestyle habits

结局指标

主要结局

Cardiorespiratory fitness

时间窗: At V1 and V3 (30 minutes)

Maximal cardiopulmonary exercise test (VO2 peak) on a cycloergometer using an incremental protocol, supervised by a cardiologist. The test started at 30 watts, increasing by 15 watts per minute until maximum capacity was reached.

次要结局

  • Exercise tolerance(At V1 and V3 (30 minutes))
  • Muscle oxygenation(At V1 and V3 (30 minutes))
  • Body composition(At V2 and V4 (5 minutes))
  • Body mass index(At V2 and V4 (5 minutes))
  • Aortic systolic and diastolic blood pressure(At V2 and V4 (15 minutes))
  • Arterial stiffness (pulse wave velocity)(At V2 and V4 (15 minutes))
  • Endothelial function (brachial artery dilation capacity)(At V2 and V4 (30 minutes))
  • Systolic and diastolic blood pressure (ambulatory blood pressure measurement)(After V2 and V4 (during 24h))
  • The Menopause-specific Quality of Life Questionnaire (MENQOL)(At V2 and V4 (10 minutes))
  • SF-36 questionnaire(At V2 and V4 (10 minutes))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Laurent Bosquet

Professor

University of Poitiers

研究点 (1)

Loading locations...

相似试验